Flowers Foods (FLO) Q2 2024 (Q&A) earnings summary

Executive summary

• Achieved solid top and bottom-line results in Q2 2024, with net income up 5% to $67.0 million and adjusted EBITDA up 7.8% to $143.5 million, driven by cost savings, improved price/mix, and business wins.

• Sales for the quarter declined 0.2% year-over-year to $1.225 billion, as positive price/mix was offset by volume declines from business exits.

• Branded retail sales grew 0.3% to $789.5 million, with strong bread performance and market share gains, while other sales fell 1.2% due to foodservice business exits.

• Transformation and digital strategy initiatives, including ERP upgrades and supply chain optimization, are ongoing.

• Portfolio strategy and targeted investments enhanced profitability in private label and away-from-home segments.

Financial highlights

• Adjusted EBITDA margin improved to 11.7% from 10.8% year-over-year, and gross margin (excluding D&A) increased to $611.6 million.

• Materials, supplies, labor, and other production costs fell to 50.1% of sales, and selling, distribution, and administrative expenses decreased to 38.5% of sales.

• Net cash from operations year-to-date was $168.4 million; capital expenditures were $61.3 million; dividends paid totaled $101.9 million.

• Restructuring charges rose to $6.8 million in the quarter, reflecting cost savings programs and reduction-in-force.

• Net debt to trailing twelve-month adjusted EBITDA ratio was 2.0x as of July 13, 2024.

Outlook and guidance

• Fiscal 2024 sales expected between $5.091 billion and $5.172 billion, with adjusted EBITDA of $524–$553 million and adjusted diluted EPS of $1.20–$1.30.

• Capital expenditures projected at $145–$155 million, including $3–$6 million for ERP upgrades; effective tax rate ~25%.

• Optimization initiatives are projected to save $40–$50 million in Fiscal 2024.

• Guidance reflects consumer resiliency, promotional activity, cost inflation mitigation, and new business wins.

• Strategic business exits and transformation initiatives are expected to have minimal impact on Q4 volume outlook.